APO RESEARCH · REPORT
Nerve Stimulator
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Product & engineering
Understand the product.
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Selected research
Market Analysis & Forecast
Global Nerve Stimulator Market Analysis and Forecast 2026-2032
Market perspective
In recent years, the global neuve stimulator has developed rapidly, with an average growth rate of about 8%.In 2018, about 190,000 nerve stimulators were produced globally, while sales were about $4 billion.In 2018, China accounted for about 2% of global production.In the next five years, China's neuve stimulators will continue to grow rapidly.Nerve stimulators are mainly divided into deep brain stimulators, spinal cord stimulators, vagus nerve stimulators, and other nerve stimulators.Among them, spinal cord stimulators accounted for the largest proportion, accounting for nearly 55% of the total market in 2018, and deep brain stimulators accounted for 16%.neuve stimulators are mainly used for pain management, Parkinson's disease, urinary incontinence and fecal incontinence, epilepsy and other diseases, of which pain management is the main application field, accounting for 55% in 2018 and Parkinson's disease accounts for 12%.The market is highly competitive.Medtronic, Abbott, Boston Scientific are the major suppliers.They have mastered key technologies and patents, and they have a fixed customer base. They have established a monopoly in the market.The industry is driven by a growing base of older people and an increase in the prevalence of chronic diseases.More than 45 percent of americans have at least one chronic condition that requires intensive care, according to the CDC.Elderly patients require intensive care, are prone to injury and take a long time to heal.
Global Nerve Stimulator key players include Medtronic, Abbott, Boston Scientific, etc. Global top three manufacturers hold a share over 70%.
North America is the largest market, with a share about 80%, followed by China, and Europe, both have a share about 15 percent.
Read the full market overview
In terms of product, Spinal Cord Stimulator is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain Management, followed by Parkinson's Disease, Epilepsy, Incontinence, etc.
This report presents an overview of global market for Nerve Stimulator, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Nerve Stimulator, also provides the sales of main regions and countries. Of the upcoming market potential for Nerve Stimulator, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Nerve Stimulator sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nerve Stimulator market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nerve Stimulator sales, projected growth trends, production technology, application and end-user industry.
Nerve Stimulator Segment by Company
Medtronic
Abbott
Boston Scientific
LivaNova
Nevro
Pins Medical
NeuroPace
Synapse Biomedical
Nerve Stimulator Segment by Type
Deep Brain Stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Nerve Stimulator Segment by Application
Pain Management
Parkinson's Disease
Incontinence
Epilepsy
Nerve Stimulator Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nerve Stimulator market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nerve Stimulator and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nerve Stimulator.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Nerve Stimulator in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Nerve Stimulator manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nerve Stimulator sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Deep Brain Stimulator
- Spinal Cord Stimulator
- Vagus Nerve Stimulator
Applications
- Pain Management
- Parkinson's Disease
- Incontinence
- Epilepsy
Companies covered
- Medtronic
- Abbott
- Boston Scientific
- LivaNova
- Nevro
- Pins Medical
- NeuroPace
- Synapse Biomedical
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Nerve Stimulator Market by Type
- 1.2.1 Global Nerve Stimulator Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Deep Brain Stimulator
- 1.2.3 Spinal Cord Stimulator
- 1.2.4 Vagus Nerve Stimulator
- 1.3 Nerve Stimulator Market by Application
- 1.3.1 Global Nerve Stimulator Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Pain Management
- 1.3.3 Parkinson's Disease
- 1.3.4 Incontinence
- 1.3.5 Epilepsy
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Nerve Stimulator Market Dynamics
- 2.1 Nerve Stimulator Industry Trends
- 2.2 Nerve Stimulator Industry Drivers
- 2.3 Nerve Stimulator Industry Opportunities and Challenges
- 2.4 Nerve Stimulator Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Nerve Stimulator Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Nerve Stimulator Revenue by Region
- 3.2.1 Global Nerve Stimulator Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Nerve Stimulator Revenue by Region (2021-2026)
- 3.2.3 Global Nerve Stimulator Revenue by Region (2027-2032)
- 3.2.4 Global Nerve Stimulator Revenue Market Share by Region (2021-2032)
- 3.3 Global Nerve Stimulator Sales Estimates and Forecasts 2021-2032
- 3.4 Global Nerve Stimulator Sales by Region
- 3.4.1 Global Nerve Stimulator Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Nerve Stimulator Sales by Region (2021-2026)
- 3.4.3 Global Nerve Stimulator Sales by Region (2027-2032)
- 3.4.4 Global Nerve Stimulator Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Nerve Stimulator Revenue by Manufacturers
- 4.1.1 Global Nerve Stimulator Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Nerve Stimulator Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Nerve Stimulator Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Nerve Stimulator Sales by Manufacturers
- 4.2.1 Global Nerve Stimulator Sales by Manufacturers (2021-2026)
- 4.2.2 Global Nerve Stimulator Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Nerve Stimulator Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Nerve Stimulator Sales Price by Manufacturers (2021-2026)
- 4.4 Global Nerve Stimulator Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Nerve Stimulator Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Nerve Stimulator Manufacturers, Product Type & Application
- 4.7 Global Nerve Stimulator Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Nerve Stimulator Market CR5 and HHI
- 4.8.2 2025 Nerve Stimulator Tier 1, Tier 2, and Tier 3
5 Nerve Stimulator Market by Type
- 5.1 Global Nerve Stimulator Revenue by Type
- 5.1.1 Global Nerve Stimulator Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Nerve Stimulator Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Nerve Stimulator Revenue Market Share by Type (2021-2032)
- 5.2 Global Nerve Stimulator Sales by Type
- 5.2.1 Global Nerve Stimulator Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Nerve Stimulator Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Nerve Stimulator Sales Market Share by Type (2021-2032)
- 5.3 Global Nerve Stimulator Price by Type
6 Nerve Stimulator Market by Application
- 6.1 Global Nerve Stimulator Revenue by Application
- 6.1.1 Global Nerve Stimulator Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Nerve Stimulator Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Nerve Stimulator Revenue Market Share by Application (2021-2032)
- 6.2 Global Nerve Stimulator Sales by Application
- 6.2.1 Global Nerve Stimulator Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Nerve Stimulator Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Nerve Stimulator Sales Market Share by Application (2021-2032)
- 6.3 Global Nerve Stimulator Price by Application
7 Company Profiles
- 7.1 Medtronic
- 7.1.1 Medtronic Company Information
- 7.1.2 Medtronic Business Overview
- 7.1.3 Medtronic Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 Medtronic Nerve Stimulator Product Portfolio
- 7.1.5 Medtronic Recent Developments
- 7.2 Abbott
- 7.2.1 Abbott Company Information
- 7.2.2 Abbott Business Overview
- 7.2.3 Abbott Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.2.4 Abbott Nerve Stimulator Product Portfolio
- 7.2.5 Abbott Recent Developments
- 7.3 Boston Scientific
- 7.3.1 Boston Scientific Company Information
- 7.3.2 Boston Scientific Business Overview
- 7.3.3 Boston Scientific Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.3.4 Boston Scientific Nerve Stimulator Product Portfolio
- 7.3.5 Boston Scientific Recent Developments
- 7.4 LivaNova
- 7.4.1 LivaNova Company Information
- 7.4.2 LivaNova Business Overview
- 7.4.3 LivaNova Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.4.4 LivaNova Nerve Stimulator Product Portfolio
- 7.4.5 LivaNova Recent Developments
- 7.5 Nevro
- 7.5.1 Nevro Company Information
- 7.5.2 Nevro Business Overview
- 7.5.3 Nevro Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.5.4 Nevro Nerve Stimulator Product Portfolio
- 7.5.5 Nevro Recent Developments
- 7.6 Pins Medical
- 7.6.1 Pins Medical Company Information
- 7.6.2 Pins Medical Business Overview
- 7.6.3 Pins Medical Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.6.4 Pins Medical Nerve Stimulator Product Portfolio
- 7.6.5 Pins Medical Recent Developments
- 7.7 NeuroPace
- 7.7.1 NeuroPace Company Information
- 7.7.2 NeuroPace Business Overview
- 7.7.3 NeuroPace Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.7.4 NeuroPace Nerve Stimulator Product Portfolio
- 7.7.5 NeuroPace Recent Developments
- 7.8 Synapse Biomedical
- 7.8.1 Synapse Biomedical Company Information
- 7.8.2 Synapse Biomedical Business Overview
- 7.8.3 Synapse Biomedical Nerve Stimulator Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.8.4 Synapse Biomedical Nerve Stimulator Product Portfolio
- 7.8.5 Synapse Biomedical Recent Developments
8 North America
- 8.1 North America Nerve Stimulator Market Size by Type
- 8.1.1 North America Nerve Stimulator Revenue by Type (2021-2032)
- 8.1.2 North America Nerve Stimulator Sales by Type (2021-2032)
- 8.1.3 North America Nerve Stimulator Price by Type (2021-2032)
- 8.2 North America Nerve Stimulator Market Size by Application
- 8.2.1 North America Nerve Stimulator Revenue by Application (2021-2032)
- 8.2.2 North America Nerve Stimulator Sales by Application (2021-2032)
- 8.2.3 North America Nerve Stimulator Price by Application (2021-2032)
- 8.3 North America Nerve Stimulator Market Size by Country
- 8.3.1 North America Nerve Stimulator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Nerve Stimulator Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Nerve Stimulator Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
- 8.3.6 Mexico
9 Europe
- 9.1 Europe Nerve Stimulator Market Size by Type
- 9.1.1 Europe Nerve Stimulator Revenue by Type (2021-2032)
- 9.1.2 Europe Nerve Stimulator Sales by Type (2021-2032)
- 9.1.3 Europe Nerve Stimulator Price by Type (2021-2032)
- 9.2 Europe Nerve Stimulator Market Size by Application
- 9.2.1 Europe Nerve Stimulator Revenue by Application (2021-2032)
- 9.2.2 Europe Nerve Stimulator Sales by Application (2021-2032)
- 9.2.3 Europe Nerve Stimulator Price by Application (2021-2032)
- 9.3 Europe Nerve Stimulator Market Size by Country
- 9.3.1 Europe Nerve Stimulator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Nerve Stimulator Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Nerve Stimulator Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Russia
- 9.3.9 Spain
- 9.3.10 Netherlands
10 China
- 10.1 China Nerve Stimulator Market Size by Type
- 10.1.1 China Nerve Stimulator Revenue by Type (2021-2032)
- 10.1.2 China Nerve Stimulator Sales by Type (2021-2032)
- 10.1.3 China Nerve Stimulator Price by Type (2021-2032)
- 10.2 China Nerve Stimulator Market Size by Application
- 10.2.1 China Nerve Stimulator Revenue by Application (2021-2032)
- 10.2.2 China Nerve Stimulator Sales by Application (2021-2032)
- 10.2.3 China Nerve Stimulator Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Nerve Stimulator Market Size by Type
- 11.1.1 Asia Nerve Stimulator Revenue by Type (2021-2032)
- 11.1.2 Asia Nerve Stimulator Sales by Type (2021-2032)
- 11.1.3 Asia Nerve Stimulator Price by Type (2021-2032)
- 11.2 Asia Nerve Stimulator Market Size by Application
- 11.2.1 Asia Nerve Stimulator Revenue by Application (2021-2032)
- 11.2.2 Asia Nerve Stimulator Sales by Application (2021-2032)
- 11.2.3 Asia Nerve Stimulator Price by Application (2021-2032)
- 11.3 Asia Nerve Stimulator Market Size by Country
- 11.3.1 Asia Nerve Stimulator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Nerve Stimulator Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Nerve Stimulator Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Nerve Stimulator Market Size by Type
- 12.1.1 SAMEA Nerve Stimulator Revenue by Type (2021-2032)
- 12.1.2 SAMEA Nerve Stimulator Sales by Type (2021-2032)
- 12.1.3 SAMEA Nerve Stimulator Price by Type (2021-2032)
- 12.2 SAMEA Nerve Stimulator Market Size by Application
- 12.2.1 SAMEA Nerve Stimulator Revenue by Application (2021-2032)
- 12.2.2 SAMEA Nerve Stimulator Sales by Application (2021-2032)
- 12.2.3 SAMEA Nerve Stimulator Price by Application (2021-2032)
- 12.3 SAMEA Nerve Stimulator Market Size by Country
- 12.3.1 SAMEA Nerve Stimulator Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Nerve Stimulator Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Nerve Stimulator Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Nerve Stimulator Value Chain Analysis
- 13.1.1 Nerve Stimulator Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Nerve Stimulator Production Mode & Process
- 13.2 Nerve Stimulator Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Nerve Stimulator Distributors
- 13.2.3 Nerve Stimulator Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst